Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines

Journal of Immunology

Volumn 167, Issue 6, 2001, Pages 3391-3397

  Pathak, M K ^a   Yi, T ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; JANUS KINASE; PROTEIN TYROSINE PHOSPHATASE; STIBOGLUCONATE SODIUM; SURAMIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DRUG ACTIVITY; ENZYME INHIBITION; HEMATOPOIETIC CELL; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 0035884996     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.6.3391     Document Type: Article

References (51)

1. The role of tyrosine phosphorylation in cell growth and disease
2. Protein tyrosine phosphatases: Mechanisms of catalysis and regulation
3. Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia
4. Chronic myelogenous leukemia
5. Protein-tyrosine phosphatases: Structure, mechanism, and inhibitor discovery
6. Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases
7. Mammalian SH2-containing protein tyrosine phosphatases
8. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling
9. Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6
10. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
11. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
12. Differential regulation of the α/β interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
13. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates 1L-3-induced tyrosine phosphorylation and mitogenesis
14. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand
15. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of potential binding sites
16. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
17. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1
18. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative response to GM-CSF: Detection of potential HCP substrates in GM-CSF signal transduction
19. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
20. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor
21. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds
22. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1
23. Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases
24. A study of the excretion of organic antimonials using a polarographic procedure
25. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis
26. Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13
27. A tyrosine-phosphorylated 110-120-kDa protein associates with the C-terminal SH2 domain of phosphotyrosine phosphatase-1D in T cell receptor-stimulated T cells
28. A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
29. SHP-1 C-terminus interacts with novel substrates p32/p30 during Epo and IL-3 mitogenic responses
30. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect
31. Interferon α activates the tyrosine kinase Lyn in haemopoietic cells
32. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated P1 3-kinase activity
33. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells
34. Protein tyrosine phosphatases: Counting the trees in the forest
35. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase
36. Direct association and dephosphorylation of Jak2 kinase by SH2 domain-containing protein tyrosine phosphatase SHP-1
37. SH2-containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells
38. Pentostam (sodium stibogluconate): A 50-year personal reminiscence
39. Signaling by the cytokine receptor superfamily
40. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
41. Genetic analysis of interferon and other mammalian signaling pathways
42. Interferon-γ and interleukin-4 in human Leishmania donovani infections
43. Exploitation of host cell signaling machinery: Activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis
44. Attenuation of γ interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: Selective inhibition of signaling through Janus kinases and Statl
45. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani
46. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired 1FN-γ-triggered JAK2 activation
47. Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection
48. Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatase inhibition: Effect on murine Leishmaniasis progression
49. Peroxovanadium-mediated protection against murine leishmaniasis: Role of the modulation of nitric oxide
50. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: A role of Raf-1 in lipopolysaccharide signaling
51. Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice